Solazyme And Bunge Enter Into Joint Venture Expansion Framework Agreement For Solazyme Bunge Renewable Oils

About Bunge Global Innovation LLC

Bunge Global Innovation is an interdisciplinary team applying the latest thinking and technologies to drive innovation across all Bunge business segments. Its mission is to scout, develop, buy, sell or license technologies that will improve Bunge’s sustainability, profitability and competitive advantage.

About Bunge Limited

Bunge Limited ( www.bunge.com, NYSE: BG) is a leading global agribusiness and food company operating in approximately 40 countries with over 35,000 employees. Bunge buys, sells, stores and transports oilseeds and grains to serve customers worldwide; processes oilseeds to make protein meal for animal feed and edible oil products for commercial customers and consumers; produces sugar and ethanol from sugarcane; mills wheat and corn to make ingredients used by food companies; and sells fertilizer in North and South America. Founded in 1818, the company is headquartered in White Plains, New York.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain forward-looking statements about Solazyme, including statements that involve risks and uncertainties concerning: [its commercialization plans; its build-out of capacity; the anticipated demand for its products; the attributes of its products and its ability to deliver profitable and sustainable growth]. When used in this press release, the words "will", "expects", "intends" and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: implementation risk in deploying new technologies; Solazyme's limited history in commercializing products; market acceptance of its products; agreement on terms for the expansion; its limited experience in constructing and operating commercial manufacturing facilities; its ability to obtain requisite regulatory approvals; its ability to enter into and maintain strategic collaborations; and its access, on favorable terms, to any required financing. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.

« First ‹ Previous 1 2 3 Next › Last »